Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Saturday morning. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Trading Up 0.6 %

NYSE:MLSS opened at $0.93 on Friday. The company has a 50-day moving average price of $1.13 and a 200-day moving average price of $0.96. The stock has a market cap of $72.07 million, a price-to-earnings ratio of -13.22 and a beta of 1.41. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of MLSS. Geode Capital Management LLC lifted its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares in the last quarter. Carnegie Investment Counsel lifted its stake in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the last quarter. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the third quarter valued at about $91,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the third quarter worth about $48,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.